Real-world efficacy of prescription and over-the-counter nicotine replacement therapy

Addiction

Volumn 97, Issue 5, 2002, Pages 505-516

  Shiffman, Saul ^a,b   Rolf, Clyde N ^c   Hellebusch, Stephen J ^d   Gorsline, Jane ^e   Gorodetzky, Charles W ^f   Chiang, Yu Kun ^g   Schleusener, Debra S ^h   Di Marino, Michael E ^a  

^a PINNEY ASSOCIATES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Marion Merrell Dow Pharmaceuticals   (United States)

^d Q2 Marketing Research Inc   (United States)

^e ALZA CORPORATION   (United States)

^f IQVIA   (United States)

^g Essence Sciences   (United States)

^h SANOFI   (France)

Author keywords

Cigarette smoking; Nicotine gum; Nicotine patch; Nicotine replacement; Over the counter; Prescription; Smoking cessation

Indexed keywords

NICOTINE; NICOTINE GUM; NON PRESCRIPTION DRUG;

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PRESCRIPTION; SMOKING CESSATION; TREATMENT OUTCOME;

ADULT; AGED; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PRESCRIPTIONS, DRUG; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 0036255475     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2002.00141.x     Document Type: Article

References (36)

1. Effectiveness of a transdermal nicotine system in smoking cessation studies
2. Use of FDA-approved pharmacologic treatments for tobacco dependence - United States, 1984-98
3. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation
4. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
5. The conference on tobacco dependence: Innovative regulatory approaches to reduce death and disease
6. Predictors of smoking celapse among self-quitters: A report from the Normative Aging Study
7. Over-the-counter nicotine patch therapy for smoking cessation: Results from randomized, double-blind, placebo-controlled, and open label trials
8. Nicotine gum, 2 and 4 mg. for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program
9. Combining behavioral therapy and pharmacotherapy for smoking cessation: An update
10. Dependence on and abuse of nicotine replacement medications: An update
11. Assessing the generalizability of smoking studies
12. The use of nicotine patches with minimal intervention
13. The bogus pipeline: A new paradigm for measuring affect and attitude
14. Attributes of successful smoking cessation interventions in medical practice: A meta-analysis of 39 controlled trials
15. A randomized trial to increase smoking intervention by physicians. Doctors helping smokers, round 1
16. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library
17. Does over-the-counter nicotine replacement therapy improve smokers' life expectance?
18. OTC nicotine patch: Effectiveness alone and with brief physician intervention
19. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia
20. The benefits and risks of over-the-counter availability of nicotine polacrilex ('nicotine gum')
21. Increasing quitting by increasing access to treatment medications: USA
22. Public health impact of over-the-counter nicotine medications
23. Efficacy of over-the-counter nicotine patch
24. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy
25. The efficacy of computer tailored smoking cessation material as a supplement to nicotine patch therapy
26. Nicotine replacement therapy for smoking cessation
27. Pharmacist counseling and outcomes of smoking cessation
28. Two and four mg nicotine chewing gum and group counselling in smoking cessation: An open, randomized, controlled trial with a 22 month follow-up
29. Transdermal nicotine for smoking cessation
30. The effectiveness of nicotine replacement therapy over-the-counter
31. Pharmacists' role in smoking cessation
32. Nicotine replacement therapy for patients with coronary artery disease